awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50124713-ADFC09F2-70F7-4259-B559-94F2D03F509C
Q50124713-ADFC09F2-70F7-4259-B559-94F2D03F509C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50124713-ADFC09F2-70F7-4259-B559-94F2D03F509C
Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eye.
P2860
Q50124713-ADFC09F2-70F7-4259-B559-94F2D03F509C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50124713-ADFC09F2-70F7-4259-B559-94F2D03F509C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8a87c432a6fc1112fa45a7e64ccf95a4dd651b23
P2860
Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans.